Back to Companypage
Business Logo
 
  • Konzern
    • About us
    • Management
    • Press
    • Events
    • Employees
    • Careers
    • Sponsoring
  • Business Units
    • Analytical Instrumentation
    • Life Science
    • Optics
  • Produkte
    • Products from A to Z
  • Investor | Media Relations
    • Key Figures
    • Share
    • Financial Reports
    • Annual Document
    • Corporate Governance
    • Ad Hoc Announcements
    • Director’s Dealings
    • Annual General Meeting
    • Financial Calendar
    • Press Releases
Company Group
  • |
  • Languages
    • English
    • Deutsch
 

zurück zur Übersicht

Analytik Jena Announces Preliminary Figures for the 2008/2009 Financial Year
  • Sales rose to over EUR 71.0 m in the instrument business
  • Operating profit (EBIT) increased by 34.0 % to EUR 6.3 m
  • Earnings per share negatively impacted by increased income tax rate

Jena, November 10, 2009 — Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) was still in line to achieve its main target in the 2008/2009 financial year and continued to enjoy strong growth despite the difficult overall economic climate. This was the announcement made by the Company today at the German Equity Conference held in Frankfurt am Main.

Over the past 2008/2009 financial year, the analytical, bioanalytical and optical systems and applications manufacturer achieved sales of EUR 71.2 m (previous year: EUR 53.1 m) in its instrument business. The Company therefore posted sales growth of 34.1 % in its core business, including the acquired subsidiaries CyBio AG and Biometra GmbH. Organic growth alone stood at 10.3 %. In the segments analytical solutions and bio solutions, Analytik Jena gained significant ground, whilst sales in optical solutions were down year-on-year.

Operating profit (EBIT) increased by 34.0 % to EUR 6.3 m (previous year: EUR 4.7 m), which corresponds to an EBIT margin of 8.9 %. Earnings before taxes (EBT) rose from EUR 2.9 m in the previous year to expectedly more than EUR 4.0 m in this period.

Also the operating cash flow with nearly EUR 6.0 m compared with the negative value of EUR -1.7 m in the previous year was developing positively.

For earnings per share the Company cannot report any resilient figures so far. This is attributable to tax burden by subsidiaries abroad that need to be audited yet. An increased income tax compared with the previous year is expected, so earnings per share will probably be close to the previous year's result.

Considering the consolidating global economy and the positive industry forecasts, Analytik Jena expects to continue its positive development and its overall growth.

The figures given in the announcement are preliminary figures. The final results for the 2008/2009 financial year (as of September 30) will be announced by the Group on December 17, 2009.

Contact:
Dana Schmidt
Analytik Jena AG
Konrad-Zuse-Strasse 1
07740 Jena  | Germany
Phone: +49 (0) 36 41  77-92 81
E-mail: ir@analytik-jena.com

 
AJ Blomesystem GmbH | AJ Cybertron GmbH | AJ eBiochip GmbH | AJ Innuscreen GmbH
AJ Roboscreen GmbH | AJZ Engineering GmbH | Biometra GmbH | CyBio AG
Analytik Jena AG | Contact | Imprint | Conditions of Use | Privacy Policy | Sitemap